Context In patients treated for prostate cancer, a rising serum prostate-specific antigen (PSA)
level is a first sign of relapse, but imaging is needed to determine the localization of the …

CONTEXT: The role of positron emission tomography (PET) and PET/computed tomography
(PET/CT) in prostate cancer (PCa) imaging is still debated, although guidelines for their use …

Prostate-specific membrane antigen (PSMA)–targeted PET imaging recently emerged as a
new method for the staging and restaging of prostate cancer. Most published studies …

The expression of prostate-specific membrane antigen (PSMA) is increased in prostate
cancer. Recently, 68Ga-PSMA (Glu-NH-CO-NH-Lys-(Ahx)-[68Ga (HBED-CC)]) was …

Purpose Positron emission tomography (PET) with choline tracers has found widespread
use for the diagnosis of prostate cancer (PC). However, choline metabolism is not increased …

Abstract Purpose 68 Ga-labelled HBED-CC-PSMA is a highly promising tracer for imaging
recurrent prostate cancer (PCa). The intention of this study was to evaluate the feasibility of …

Objectives Our aim is to present a summary of the 2010 version of the European Association
of Urology (EAU) guidelines on the treatment of advanced, relapsing, and castration …

Prostate cancer is biologically and clinically a heterogeneous disease that makes imaging
evaluation challenging. The role of imaging in prostate cancer should include diagnosis …

Aim The increase of prostate-specific antigen (PSA) after radical retropubic prostatectomy
(RP) or external beam radiotherapy (EBRT) is the most sensitive tool for detecting prostate …

Background Diagnosing the biochemical recurrence (BCR) of prostate cancer (PCa) is a
clinical challenge, and early detection of BCR can help patients receive optimal treatment …